search
Back to results

Management of Shock in Children With SAM or Severe Underweight and Diarrhea

Primary Purpose

Shock Hypovolemic, Shock, Septic, Blood Transfusion

Status
Recruiting
Phase
Phase 3
Locations
Bangladesh
Study Type
Interventional
Intervention
Dopamine
adrenaline
Blood Transfusion
Sponsored by
International Centre for Diarrhoeal Disease Research, Bangladesh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Shock Hypovolemic focused on measuring Severe acute malnutrition, Children, Shock, Cholera, Dehydrating diarrhea, Severe underweight

Eligibility Criteria

1 Month - 59 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Children of either sex with SAM or severe underweight and diarrhea
  2. Age: 1-59 months
  3. Children with cerebral palsy (CP) and/or developmental dealy
  4. Fluid refractory shock

Exclusion Criteria:

  1. Severe anemia (hemoglobin< 5 gm/dl) who will require a blood transfusion
  2. Sclerema
  3. Congenital anomalies (TOF/ASD/VSD/Trisomy 21, etc.)
  4. Having a rare blood group (negative blood groups)
  5. A child requiring cardio-pulmonary resuscitation during screening or having gasping respiration

Sites / Locations

  • Icddr,BRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

Dopamine arm

Adrenaline arm

Blood transfusion arm

Arm Description

Children in the dopamine arm (Treatment plan A) will receive dopamine, 8 microgram/kg/min (increasing the dose after 15 minutes to 12 microgram/kg/min to a maximum of 15 microgram/kg/min)

Children in the adrenaline arm (Treatment plan B) will receive adrenaline, 0.1 microgram/kg/min (increasing the dose after 15 minutes to 0.2 microgram/kg.min to a maximum of 0.3 microgram/kg.min)

Children in the blood transfusion arm (Treatment plan C) will receive a transfusion of whole human blood in a dose of 10 mL/kg over 2-3 hours. While the blood transfusion is being arranged, IV fluid would be given @ of 3 ml per kg per hour

Outcomes

Primary Outcome Measures

Case fatality rate
Number of mortalities among SAM or severe underweight children presenting with diarrhea and fluid refractory shock who would receive WHO standard fluid therapy followed by dopamine or adrenaline, compared to those receiving blood transfusion after WHO standard fluid therapy

Secondary Outcome Measures

Treatment failure rates
Number of children where we failed to achieve the goal of resuscitation after starting any one of the interventions
Need for mechanical ventilation
Number of children who would require mechanical ventilation
Heart failure
Number of children who developed heart failure. Heart failure will be assessed on the basis of - age-specific tachypnea, tachycardia, enlarged tender liver, pedal edema, basal crackles and/or gallop and response to furosemide (combination of findings).
Length of ICU stay
Time a child stays in ICU
Time-to-achieve recovery
Required times (minutes) for resuscitation of a child after randomization to a specific arms
Left ventricular function of the study participants
Evaluation of left ventricular function (hyperdynamic or normal) by cardiac USG at enrollment, at time of heart failure (if any)
Right ventricular function of the study participants
Evaluation of right ventricular function (hyperdynamic or normal) by cardiac ultrasound at enrollment, at time of heart failure (if any)
Inferior vena cava collapsibility of the study participants
Evaluation of Inferior vena cava collapsibility by cardiac ultrasound at enrollment, at time of heart failure (if any)
Length of hospital stay
Time a child stays in the hospital
Mean arterial pressure (MAP) stabilization at 48 hours
Number of children whose MAP was stabilized at 48 hours

Full Information

First Posted
February 1, 2021
Last Updated
December 18, 2022
Sponsor
International Centre for Diarrhoeal Disease Research, Bangladesh
Collaborators
University of British Columbia, Muhimbili University of Health and Allied Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT04750070
Brief Title
Management of Shock in Children With SAM or Severe Underweight and Diarrhea
Official Title
Randomized Controlled Trial of Dopamine, Adrenaline, and Blood Transfusion for Treatment of Fluid Refractory Shock in Children With Severe Acute Malnutrition or Severe Underweight and Cholera or Other Dehydrating Diarrheas
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
August 17, 2021 (Actual)
Primary Completion Date
February 2023 (Anticipated)
Study Completion Date
April 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
International Centre for Diarrhoeal Disease Research, Bangladesh
Collaborators
University of British Columbia, Muhimbili University of Health and Allied Sciences

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Diarrhea is one of the leading causes of under-five childhood mortality and accounts for 8% of 5.4 million global under-5 deaths. The coexistence of sepsis and hypovolemic shock in children with severe acute malnutrition (SAM) having diarrhea is common. At Dhaka hospital of icddr,b, the death rate is as high as 40% and 69% in children with severe sepsis and septic shock respectively with co-morbidities such as severe malnutrition. The conventional management of SAM children with features of severe sepsis recommended by WHO includes administration of boluses of isotonic saline followed by blood transfusion in unresponsive cases with septic shock; whereas the Surviving Sepsis Campaign (SSC) guideline recommends vasoactive support. To date, no study has evaluated systematically the effects of inotrope(s) and vasopressor or blood transfusion in children with dehydrating diarrhea (for example, in cholera) and SAM having shock and unresponsive to WHO standard fluid therapy. This randomized trial will generate evidence whether inotrope and vasopressor or blood transfusion should be selected for severely malnourished children having hypotensive shock and who failed to respond to WHO standard fluid bolus.
Detailed Description
Background: Burden: Burden: Diarrhea is one of the leading causes of under-five childhood mortality and accounts for 8% of 5.4 million global under-5 deaths. Co-morbidity of severe acute malnutrition (SAM) and shock in children with diarrhea is associated with increased mortality. Nearly half of the patients admitted to the Intensive Care Unit (ICU) of Dhaka Hospital of icddr,b present with sepsis. Data demonstrates that about 43% of children progressed from severe sepsis to septic shock despite receiving recommended treatment. The death rate was found to be as high as 40% and 69% in children with severe sepsis and septic shock respectively with co-morbidities such as severe malnutrition. Knowledge gap: The conventional management of SAM children with features of severe sepsis recommended by WHO include administration of boluses of isotonic saline followed by blood transfusion in unresponsive cases with septic shock. However, a recent African study reported significantly higher mortality among children with features of severe sepsis when they were treated with boluses. To date, no study has evaluated systematically the effects of inotrope or vasopressor or blood transfusion in children with dehydrating diarrhea (for example, in cholera) and SAM having shock and unresponsive to WHO standard fluid therapy. Relevance: If this randomized trial signifies survival benefit from a blood transfusion, inotrope or vasopressor in the management of fluid refractory shock in children with severe acute malnutrition and cholera or other dehydrating diarrheas, then this approach would be a good candidate for implementation in the management of such children especially in developing countries Hypothesis: We hypothesize that the death rates will be significantly lower in children with SAM or severe underweight, dehydrating diarrhea and fluid refractory shock who will be treated with dopamine or adrenaline compared to blood transfusion, after treatment failure with WHO standard bolus intravenous fluid therapy. Objectives: To reduce mortality of the SAM or severely underweight children presenting with diarrhea and fluid refractory shock who will receive WHO standard fluid therapy followed by dopamine or adrenaline, compared to those receiving blood transfusion after WHO standard fluid therapy. Methods: This will be a randomized, three-arm, controlled, non-masked clinical trial in children 1- 59 months old with SAM or severely underweight and fluid refractory shock. It will compare the efficacy of WHO-recommended fluid resuscitation followed by dopamine or adrenaline administration versus WHO recommended fluid resuscitation followed by blood transfusion. After parental written informed consent, children, in addition to usual supportive care, will be allocated to the study interventions following randomization.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Shock Hypovolemic, Shock, Septic, Blood Transfusion, Adrenaline, Dopamine
Keywords
Severe acute malnutrition, Children, Shock, Cholera, Dehydrating diarrhea, Severe underweight

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Model Description
Systematic evaluation of the effects of inotrope(s) and vasopressor or blood transfusion in children with dehydrating diarrhea (for example, in cholera) and SAM or severe underweight having shock and unresponsive to WHO standard fluid therapy
Masking
None (Open Label)
Allocation
Randomized
Enrollment
135 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Dopamine arm
Arm Type
Experimental
Arm Description
Children in the dopamine arm (Treatment plan A) will receive dopamine, 8 microgram/kg/min (increasing the dose after 15 minutes to 12 microgram/kg/min to a maximum of 15 microgram/kg/min)
Arm Title
Adrenaline arm
Arm Type
Experimental
Arm Description
Children in the adrenaline arm (Treatment plan B) will receive adrenaline, 0.1 microgram/kg/min (increasing the dose after 15 minutes to 0.2 microgram/kg.min to a maximum of 0.3 microgram/kg.min)
Arm Title
Blood transfusion arm
Arm Type
Active Comparator
Arm Description
Children in the blood transfusion arm (Treatment plan C) will receive a transfusion of whole human blood in a dose of 10 mL/kg over 2-3 hours. While the blood transfusion is being arranged, IV fluid would be given @ of 3 ml per kg per hour
Intervention Type
Drug
Intervention Name(s)
Dopamine
Intervention Description
Children will receive dopamine, 8 microgram/kg.min (increasing the dose after 15 minutes to 12 microgram/kg/min to a maximum of 15 microgram/kg/min)
Intervention Type
Drug
Intervention Name(s)
adrenaline
Other Intervention Name(s)
Epinephrine
Intervention Description
Children will receive adrenaline, 0.1 microgram/kg/min (increasing the dose after 15 minutes to 0.2 microgram/kg.min to a maximum of 0.3 microgram/kg.min)
Intervention Type
Drug
Intervention Name(s)
Blood Transfusion
Other Intervention Name(s)
Blood
Intervention Description
Children will receive a transfusion of whole human blood in a dose of 10 mL/kg over 2-3 hours. While the blood transfusion is being arranged, IV fluid would be given @ of 3 ml per kg per hour
Primary Outcome Measure Information:
Title
Case fatality rate
Description
Number of mortalities among SAM or severe underweight children presenting with diarrhea and fluid refractory shock who would receive WHO standard fluid therapy followed by dopamine or adrenaline, compared to those receiving blood transfusion after WHO standard fluid therapy
Time Frame
28 days (± 3 days)
Secondary Outcome Measure Information:
Title
Treatment failure rates
Description
Number of children where we failed to achieve the goal of resuscitation after starting any one of the interventions
Time Frame
Through study completion, an average of 7 days
Title
Need for mechanical ventilation
Description
Number of children who would require mechanical ventilation
Time Frame
Through study completion, an average of 7 days
Title
Heart failure
Description
Number of children who developed heart failure. Heart failure will be assessed on the basis of - age-specific tachypnea, tachycardia, enlarged tender liver, pedal edema, basal crackles and/or gallop and response to furosemide (combination of findings).
Time Frame
Through study completion, an average of 7 days
Title
Length of ICU stay
Description
Time a child stays in ICU
Time Frame
Through study completion, an average of 7 days
Title
Time-to-achieve recovery
Description
Required times (minutes) for resuscitation of a child after randomization to a specific arms
Time Frame
3-4 hours
Title
Left ventricular function of the study participants
Description
Evaluation of left ventricular function (hyperdynamic or normal) by cardiac USG at enrollment, at time of heart failure (if any)
Time Frame
Through study completion, an average of 7 days
Title
Right ventricular function of the study participants
Description
Evaluation of right ventricular function (hyperdynamic or normal) by cardiac ultrasound at enrollment, at time of heart failure (if any)
Time Frame
Through study completion, an average of 7 days
Title
Inferior vena cava collapsibility of the study participants
Description
Evaluation of Inferior vena cava collapsibility by cardiac ultrasound at enrollment, at time of heart failure (if any)
Time Frame
Through study completion, an average of 7 days
Title
Length of hospital stay
Description
Time a child stays in the hospital
Time Frame
variable (days to months)
Title
Mean arterial pressure (MAP) stabilization at 48 hours
Description
Number of children whose MAP was stabilized at 48 hours
Time Frame
48 hours from the point of inclusion in the study

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Month
Maximum Age & Unit of Time
59 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children of either sex with SAM or severe underweight and diarrhea Age: 1-59 months Children with cerebral palsy (CP) and/or developmental dealy Fluid refractory shock Exclusion Criteria: Severe anemia (hemoglobin< 5 gm/dl) who will require a blood transfusion Sclerema Congenital anomalies (TOF/ASD/VSD/Trisomy 21, etc.) Having a rare blood group (negative blood groups) A child requiring cardio-pulmonary resuscitation during screening or having gasping respiration
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Monira Sarmin, MBBS, MCPS
Phone
+8801718596947
Ext
2186
Email
drmonira@icddrb.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tahmeed Ahmed, PhD
Organizational Affiliation
International Centre for Diarrhoeal Disease Research, Bangladesh
Official's Role
Principal Investigator
Facility Information:
Facility Name
Icddr,B
City
Dhaka
ZIP/Postal Code
1000
Country
Bangladesh
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Monira Sarmin, MCPS
Email
drmonira@icddrb.org
First Name & Middle Initial & Last Name & Degree
Tahmeed Ahmed, PhD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
24006557
Citation
Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses. 2nd edition. Geneva: World Health Organization; 2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK154447/
Results Reference
background
Citation
AABB. Technical Manual. 19th ed. Fung MK, Eder AF, Spitalnik SL, Westhoff CM, editors. United States.
Results Reference
background
Citation
Green REB, Klostermann DA. The Antiglobulin Test. In: Harmening D, editor. Modern Blood Banking & Transfusion Practices. 6th ed. Philadelphia: F.A. Davis. p. 107-10.
Results Reference
background
PubMed Identifier
21627690
Citation
Chisti MJ, Pietroni MA, Smith JH, Bardhan PK, Salam MA. Predictors of death in under-five children with diarrhoea admitted to a critical care ward in an urban hospital in Bangladesh. Acta Paediatr. 2011 Dec;100(12):e275-9. doi: 10.1111/j.1651-2227.2011.02368.x. Epub 2011 Jun 21.
Results Reference
result
PubMed Identifier
24661049
Citation
Sarmin M, Ahmed T, Bardhan PK, Chisti MJ. Specialist hospital study shows that septic shock and drowsiness predict mortality in children under five with diarrhoea. Acta Paediatr. 2014 Jul;103(7):e306-11. doi: 10.1111/apa.12640. Epub 2014 Apr 11.
Results Reference
result
PubMed Identifier
10371570
Citation
Ahmed T, Ali M, Ullah MM, Choudhury IA, Haque ME, Salam MA, Rabbani GH, Suskind RM, Fuchs GJ. Mortality in severely malnourished children with diarrhoea and use of a standardised management protocol. Lancet. 1999 Jun 5;353(9168):1919-22. doi: 10.1016/S0140-6736(98)07499-6.
Results Reference
result
PubMed Identifier
26440279
Citation
Chisti MJ, Salam MA, Bardhan PK, Faruque AS, Shahid AS, Shahunja KM, Das SK, Hossain MI, Ahmed T. Severe Sepsis in Severely Malnourished Young Bangladeshi Children with Pneumonia: A Retrospective Case Control Study. PLoS One. 2015 Oct 6;10(10):e0139966. doi: 10.1371/journal.pone.0139966. eCollection 2015.
Results Reference
result
PubMed Identifier
29318195
Citation
Sarker AR, Sultana M, Mahumud RA, Ali N, Huda TM, Salim Uzzaman M, Haider S, Rahman H, Islam Z, Khan JAM, Van Der Meer R, Morton A. Economic costs of hospitalized diarrheal disease in Bangladesh: a societal perspective. Glob Health Res Policy. 2018 Jan 5;3:1. doi: 10.1186/s41256-017-0056-5. eCollection 2018.
Results Reference
result
PubMed Identifier
1632474
Citation
Guerrant RL, Schorling JB, McAuliffe JF, de Souza MA. Diarrhea as a cause and an effect of malnutrition: diarrhea prevents catch-up growth and malnutrition increases diarrhea frequency and duration. Am J Trop Med Hyg. 1992 Jul;47(1 Pt 2):28-35. doi: 10.4269/ajtmh.1992.47.28.
Results Reference
result
PubMed Identifier
19593244
Citation
Chisti MJ, Saha S, Roy CN, Salam MA. Predictors of bacteremia in infants with diarrhea and systemic inflammatory response syndrome attending an urban diarrheal treatment center in a developing country. Pediatr Crit Care Med. 2010 Jan;11(1):92-7. doi: 10.1097/PCC.0b013e3181b063e1.
Results Reference
result
PubMed Identifier
24196006
Citation
Ranjit S, Aram G, Kissoon N, Ali MK, Natraj R, Shresti S, Jayakumar I, Gandhi D. Multimodal monitoring for hemodynamic categorization and management of pediatric septic shock: a pilot observational study*. Pediatr Crit Care Med. 2014 Jan;15(1):e17-26. doi: 10.1097/PCC.0b013e3182a5589c.
Results Reference
result
PubMed Identifier
28509730
Citation
Davis AL, Carcillo JA, Aneja RK, Deymann AJ, Lin JC, Nguyen TC, Okhuysen-Cawley RS, Relvas MS, Rozenfeld RA, Skippen PW, Stojadinovic BJ, Williams EA, Yeh TS, Balamuth F, Brierley J, de Caen AR, Cheifetz IM, Choong K, Conway E Jr, Cornell T, Doctor A, Dugas MA, Feldman JD, Fitzgerald JC, Flori HR, Fortenberry JD, Graciano AL, Greenwald BM, Hall MW, Han YY, Hernan LJ, Irazuzta JE, Iselin E, van der Jagt EW, Jeffries HE, Kache S, Katyal C, Kissoon N, Kon AA, Kutko MC, MacLaren G, Maul T, Mehta R, Odetola F, Parbuoni K, Paul R, Peters MJ, Ranjit S, Reuter-Rice KE, Schnitzler EJ, Scott HF, Torres A Jr, Weingarten-Arams J, Weiss SL, Zimmerman JJ, Zuckerberg AL. American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock. Crit Care Med. 2017 Jun;45(6):1061-1093. doi: 10.1097/CCM.0000000000002425. Erratum In: Crit Care Med. 2017 Sep;45(9):e993. Kissoon, Niranjan Tex [corrected to Kissoon, Niranjan]; Weingarten-Abrams, Jacki [corrected to Weingarten-Arams, Jacki].
Results Reference
result
PubMed Identifier
21615299
Citation
Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T, Brent B, Evans JA, Tibenderana JK, Crawley J, Russell EC, Levin M, Babiker AG, Gibb DM; FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011 Jun 30;364(26):2483-95. doi: 10.1056/NEJMoa1101549. Epub 2011 May 26.
Results Reference
result
PubMed Identifier
9842034
Citation
Seri I, Abbasi S, Wood DC, Gerdes JS. Regional hemodynamic effects of dopamine in the sick preterm neonate. J Pediatr. 1998 Dec;133(6):728-34. doi: 10.1016/s0022-3476(98)70141-6.
Results Reference
result
PubMed Identifier
23496872
Citation
Maitland K, George EC, Evans JA, Kiguli S, Olupot-Olupot P, Akech SO, Opoka RO, Engoru C, Nyeko R, Mtove G, Reyburn H, Brent B, Nteziyaremye J, Mpoya A, Prevatt N, Dambisya CM, Semakula D, Ddungu A, Okuuny V, Wokulira R, Timbwa M, Otii B, Levin M, Crawley J, Babiker AG, Gibb DM; FEAST trial group. Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial. BMC Med. 2013 Mar 14;11:68. doi: 10.1186/1741-7015-11-68.
Results Reference
result
PubMed Identifier
8194289
Citation
Phornphatkul C, Pongprot Y, Suskind R, George V, Fuchs G. Cardiac function in malnourished children. Clin Pediatr (Phila). 1994 Mar;33(3):147-54. doi: 10.1177/000992289403300304.
Results Reference
result
PubMed Identifier
26323041
Citation
Ventura AM, Shieh HH, Bousso A, Goes PF, de Cassia F O Fernandes I, de Souza DC, Paulo RL, Chagas F, Gilio AE. Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as First-Line Vasoactive Drugs in Pediatric Septic Shock. Crit Care Med. 2015 Nov;43(11):2292-302. doi: 10.1097/CCM.0000000000001260.
Results Reference
result
PubMed Identifier
27673385
Citation
Ramaswamy KN, Singhi S, Jayashree M, Bansal A, Nallasamy K. Double-Blind Randomized Clinical Trial Comparing Dopamine and Epinephrine in Pediatric Fluid-Refractory Hypotensive Septic Shock. Pediatr Crit Care Med. 2016 Nov;17(11):e502-e512. doi: 10.1097/PCC.0000000000000954.
Results Reference
result
PubMed Identifier
32032273
Citation
Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, Nadel S, Schlapbach LJ, Tasker RC, Argent AC, Brierley J, Carcillo J, Carrol ED, Carroll CL, Cheifetz IM, Choong K, Cies JJ, Cruz AT, De Luca D, Deep A, Faust SN, De Oliveira CF, Hall MW, Ishimine P, Javouhey E, Joosten KFM, Joshi P, Karam O, Kneyber MCJ, Lemson J, MacLaren G, Mehta NM, Moller MH, Newth CJL, Nguyen TC, Nishisaki A, Nunnally ME, Parker MM, Paul RM, Randolph AG, Ranjit S, Romer LH, Scott HF, Tume LN, Verger JT, Williams EA, Wolf J, Wong HR, Zimmerman JJ, Kissoon N, Tissieres P. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med. 2020 Feb;21(2):e52-e106. doi: 10.1097/PCC.0000000000002198.
Results Reference
result
PubMed Identifier
30065491
Citation
Sun JT. New Advances in Emergency Ultrasound Protocols for Shock. J Med Ultrasound. 2017 Oct-Dec;25(4):191-194. doi: 10.1016/j.jmu.2017.09.005. Epub 2017 Dec 6. No abstract available.
Results Reference
result
PubMed Identifier
28144779
Citation
Sekiguchi H, Harada Y, Villarraga HR, Mankad SV, Gajic O. Focused cardiac ultrasound in the early resuscitation of severe sepsis and septic shock: a prospective pilot study. J Anesth. 2017 Aug;31(4):487-493. doi: 10.1007/s00540-017-2312-8. Epub 2017 Jan 31.
Results Reference
result
PubMed Identifier
31821418
Citation
McQuilten ZK, Cooper DJ. Age of Red Blood Cells for Transfusion in Critically Ill Pediatric Patients. JAMA. 2019 Dec 10;322(22):2175-2176. doi: 10.1001/jama.2019.17476. No abstract available.
Results Reference
result
PubMed Identifier
28316439
Citation
Tiwari AK, Aggarwal G, Dara RC, Arora D, Gupta GK, Raina V. First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients. Asian J Transfus Sci. 2017 Jan-Jun;11(1):40-44. doi: 10.4103/0973-6247.200774.
Results Reference
result

Learn more about this trial

Management of Shock in Children With SAM or Severe Underweight and Diarrhea

We'll reach out to this number within 24 hrs